Results 11 to 20 of about 70,315 (252)

Acute-on-chronic liver failure or Alcoholic Hepatitis? In patients with chronic alcoholic liver disease

open access: yesAnnals of Hepatology, 2022
Introduction and Objectives: This study aimed to determine if there is an overlap of alcoholic hepatitis and ACLF criteria and if the presence of ACLF predicts a poor prognosis.
R Chicas López   +7 more
doaj   +1 more source

P-1 PREVALENCE AND EPIDEMOLOGY OF BACTERIAL INFECTIONS IN PATIENTS WITH ALCOHOLIC HEPATITIS: A RETROSPECTIVE STUDY OF PATIENTS ADMITTED AT THE SAN RAFAEL DE ALAHUELA HOSPITAL, COSTA RICA

open access: yesAnnals of Hepatology, 2021
Introduction: Bacterial infections in patients with alcoholic hepatitis have a high incidence and can contribute to the developments of organ failure and death. Aims: To determinate the prevalence and epidemiology of bacterial infections in patients with
Alejandra Ochoa   +2 more
doaj   +1 more source

Alcoholic Hepatitis: A Common Disease with Uncommon Presentation

open access: yesCase Reports in Gastroenterology, 2020
Alcoholic liver disease is one of the leading causes of hepatitis, cirrhosis, liver failure, and hepatic carcinoma. Alcoholic hepatitis refers to the acute onset of symptomatic hepatitis.
Pratik Khatiwada   +2 more
doaj   +1 more source

Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis. [PDF]

open access: yesPLoS ONE, 2016
Data on quantitative metabolic liver functions in the life-threatening disease alcoholic hepatitis are scarce. Urea synthesis is an essential metabolic liver function that plays a key regulatory role in nitrogen homeostasis.
Emilie Glavind   +6 more
doaj   +1 more source

Pathophysiological Prerequisites and Therapeutic Potential of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis

open access: yesАрхивъ внутренней медицины, 2022
Due to the high morbidity and mortality, the problem of severe alcoholic hepatitis has not lost its relevance to date. In the absence of specific therapy, the associated to him one-month survival rate is low, and mortality rates reach 30-50 %.
D. V. Garbuzenko
doaj   +1 more source

Serum Acylcarnitines Associated with High Short-Term Mortality in Patients with Alcoholic Hepatitis

open access: yesBiomolecules, 2021
Alcohol-related liver disease is one of the most prevalent liver diseases in the United States. Early stages of alcohol-related liver disease are characterized by accumulation of triglycerides in hepatocytes.
Bei Gao   +3 more
doaj   +1 more source

Recent advances in alcoholic hepatitis [version 1; peer review: 3 approved]

open access: yesF1000Research, 2020
Alcoholic hepatitis is the severest clinical presentation of alcoholic liver disease. Lacking an effective pharmacologic treatment, alcoholic hepatitis is associated with a poor prognosis and its recovery relies mostly on abstinence.
Vikrant Rachakonda   +2 more
doaj   +1 more source

Metabolomics Discloses a New Non-invasive Method for the Diagnosis and Prognosis of Patients with Alcoholic Hepatitis

open access: yesAnnals of Hepatology, 2019
Introduction and aims. Alcoholic hepatitis is the most severe manifestation of alcoholic liver disease. Unfortunately, there are still some unresolved issues in the diagnosis and management of this disease, such as the need of histological diagnosis, an ...
Javier Michelena   +9 more
doaj   +1 more source

NAFLD‐related hepatocellular carcinoma: The growing challenge

open access: yesHepatology, EarlyView., 2022
Risk and protective factors for NAFLD‐related hepatocellular carcinoma Abstract Hepatocellular carcinoma (HCC) is a common cause of cancer‐related mortality and morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the burden of disease exponentially.
Pir Ahmad Shah   +2 more
wiley   +1 more source

Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice

open access: yesHepatology, EarlyView., 2022
Graphical summary of obesity‐induced NASH progression by LCN2 targeted to HSC activation. Abstract Background and Aims In obesity and type 2 diabetes mellitus, leptin promotes insulin resistance and contributes to the progression of NASH via activation of hepatic stellate cells (HSCs).
Kyung Eun Kim   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy